Conference
Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with platinum-based doublet chemotherapy (PT-DC) in advanced non-small cell lung cancer (NSCLC).
Authors
Antonia SJ; Brahmer JR; Gettinger SN; Chow LQM; Juergens RA; Shepherd FA; Laurie SA; Gerber DE; Goldman JW; Shen Y
Volume
32
Pagination
pp. 8113-8113
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2014
DOI
10.1200/jco.2014.32.15_suppl.8113
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X